LINDSEY LEONARD: Open Payments
NPI 1295449692 · LEES SUMMIT, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$445 in 18 payments from 11 companies in 2025. Trend: 2023 $487 · 2024 $421 · 2025 $445
Food & beverage: $445
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 5 | $121 |
| GENZYME CORPORATION | 3 | $75 |
| Smith+Nephew, Inc. | 1 | $60 |
| Phathom Pharmaceuticals, Inc. | 2 | $38 |
| Ascendis Pharma Endocrinology Inc | 1 | $29 |
| Integra LifeSciences Corporation | 1 | $28 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $24 |
| AERIN MEDICAL INC. | 1 | $19 |
| Merck Sharp & Dohme LLC | 1 | $19 |
| Optinose US, Inc. | 1 | $16 |
Products named: DUPIXENT, TULA, VOQUEZNA, Yorvipath, ACCLARENT AERA, VIVAER STYLUS, KEYTRUDA, Xhance.
Industry payments across MO — which companies pay providers there.
